Tone mix
Week by week 52 weeks
Share of Pfizer Inc.'s 1,976 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 6, 2026 · tone -46Belgian court ruling in Pfizer case leads to garnishment of funds destined for Romania via ROMATSA-62
- Week of May 25, 2026 · tone +79Innovent Biologics and Pfizer Enter Global Strategic Collaboration to Accelerate Development of Innovative Oncology Medicines+61
- Week of Apr 6, 2026 · tone -29Prediction: In 5 Years, You'll Wish You Bought Pfizer Stock Today-54
- Week of Jan 12, 2026 · tone +46Pfizer's BRAFTOVI Regimen Boosts Response Rates In BRAF V600E-Mutant Metastatic Colorectal Cancer+47
- Week of Feb 23, 2026 · tone +56Is Pfizer Stock an Underrated Healthcare Investment Play?+44
- Week of Sep 21, 2026 · tone -18AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?-39
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Pfizer Inc. in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 25 | +19 |
| Last 30 sessions | 158 | -5 |
| Last 90 sessions | 531 | +8 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Wednesday, October 28, 2026
5 headlines, average tone +19: 3 positive, 0 neutral and 2 negative. Showing all 5.
- www.themarketsdaily.com · 1 outletPfizer Stock Earnings Estimates Lowered by Erste Group BankNegative
- www.rttnews.com · 1 outletPfizer's ELREXFIO Succeeds In Phase 3 Trial For Multiple MyelomaPositive
- www.miragenews.com · 1 outletPfizer's Elrexfio Beats Standard Regimens in Phase 3 TrialPositive
- www.rttnews.com · 1 outletPfizer's ELREXFIO Meets Phase 3 Endpoint; Median PFS Not Yet Reached; Stock DownNegative
- econotimes.com · 1 outletPfizer Says Elrexfio Reduced Progression Risk in Myeloma TrialPositive
Show the table · 5 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pfizer Stock Earnings Estimates Lowered by Erste Group Bank | www.themarketsdaily.com | 1 | Negative |
| Pfizer's ELREXFIO Succeeds In Phase 3 Trial For Multiple Myeloma | www.rttnews.com | 1 | Positive |
| Pfizer's Elrexfio Beats Standard Regimens in Phase 3 Trial | www.miragenews.com | 1 | Positive |
| Pfizer's ELREXFIO Meets Phase 3 Endpoint; Median PFS Not Yet Reached; Stock Down | www.rttnews.com | 1 | Negative |
| Pfizer Says Elrexfio Reduced Progression Risk in Myeloma Trial | econotimes.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Tuesday, October 27, 2026
4 headlines, average tone +57: 3 positive, 0 neutral and 1 negative. Showing all 4.
- www.rttnews.com · 1 outletPfizer Secures Expanded FDA Label For Talzenna-Xtandi In HRR-Mutated Metastatic Prostate CancerPositive
- www.financial-news.co.uk · 1 outletPfizer wins FDA approval for Talzenna-Xtandi in earlier prostate cancerPositive
- www.miragenews.com · 1 outletFDA Approves Pfizer Combo for Earlier Prostate Cancer TreatmentPositive
- 247wallst.com · 1 outletModerna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds SteadyNegative
Show the table · 4 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pfizer Secures Expanded FDA Label For Talzenna-Xtandi In HRR-Mutated Metastatic Prostate Cancer | www.rttnews.com | 1 | Positive |
| Pfizer wins FDA approval for Talzenna-Xtandi in earlier prostate cancer | www.financial-news.co.uk | 1 | Positive |
| FDA Approves Pfizer Combo for Earlier Prostate Cancer Treatment | www.miragenews.com | 1 | Positive |
| Moderna Tumbles 7% as Cancer Vaccine Selloff Deepens; BioNTech Falls 3%, Pfizer Holds Steady | 247wallst.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
8 headlines, average tone +8: 4 positive, 1 neutral and 3 negative. Showing all 8.
- www.aol.com · 3 outletsPfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might SeemPositive
- www.zerohedge.com · 2 outletsAppeals Court Throws Out Alex Berenson's Case Against Pfizer ExecutivesPositive
- www.miragenews.com · 1 outletPfizer's 25-Valent Pediatric Vaccine Shows Strong Phase 2 DataPositive
- www.publicradioeast.org · 1 outletPharmaceutical giant Pfizer cutting jobs at manufacturing plants in Rocky Mount and SanfordNegative
- www.aol.com · 1 outletModerna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer SlipNegative
- www.wsoctv.com · 1 outletPfizer announces layoffs at NC facilitiesNegative
- www.bignewsnetwork.com · 1 outletAbu Dhabi Public Health Centre, Pfizer collaborate to explore AI, technology-enabled public health innovationPositive
- www.medicaldaily.com · 1 outletPfizer's Atirmociclib Held Off Breast Cancer Progression for 9.4 Months Versus 6.6 After CDK4/6 Drugs Stopped WorkingNeutral
Show the table · 8 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pfizer's Dividend Yield Is One of the Highest in the S&P 500. Here's Why the Dividend Is Safer Than It Might Seem | www.aol.com | 3 | Positive |
| Appeals Court Throws Out Alex Berenson's Case Against Pfizer Executives | www.zerohedge.com | 2 | Positive |
| Pfizer's 25-Valent Pediatric Vaccine Shows Strong Phase 2 Data | www.miragenews.com | 1 | Positive |
| Pharmaceutical giant Pfizer cutting jobs at manufacturing plants in Rocky Mount and Sanford | www.publicradioeast.org | 1 | Negative |
| Moderna Sinks 4% After 18% Plunge as Melanoma Vaccine Selloff Extends; Merck and Pfizer Slip | www.aol.com | 1 | Negative |
| Pfizer announces layoffs at NC facilities | www.wsoctv.com | 1 | Negative |
| Abu Dhabi Public Health Centre, Pfizer collaborate to explore AI, technology-enabled public health innovation | www.bignewsnetwork.com | 1 | Positive |
| Pfizer's Atirmociclib Held Off Breast Cancer Progression for 9.4 Months Versus 6.6 After CDK4/6 Drugs Stopped Working | www.medicaldaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
6 headlines, average tone +13: 2 positive, 3 neutral and 1 negative. Showing all 6.
- www.aol.com · 3 outletsWhat Higher Interest Rates Mean for Dividend Stocks Like AbbVie and PfizerNeutral
- www.fool.com · 3 outletsBristol Myers Squibb vs. Pfizer: Consistency vs. Scale in RevenueNeutral
- 247wallst.com · 2 outletsPfizer's High Dividend Yield May Be a Warning. Here's How Merck ComparesNegative
- www.investors.com · 2 outletsPfizer Stock: How To Boost The Dividend Yield On This Drug GiantPositive
- www.fool.com · 2 outletsBetter Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb?Neutral
- www.theepochtimes.com · 1 outletAppeals Court Throws Out Alex Berenson's Case Against Pfizer ExecutivesPositive
Show the table · 6 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer | www.aol.com | 3 | Neutral |
| Bristol Myers Squibb vs. Pfizer: Consistency vs. Scale in Revenue | www.fool.com | 3 | Neutral |
| Pfizer's High Dividend Yield May Be a Warning. Here's How Merck Compares | 247wallst.com | 2 | Negative |
| Pfizer Stock: How To Boost The Dividend Yield On This Drug Giant | www.investors.com | 2 | Positive |
| Better Dividend Stock to Buy and Hold: Pfizer or Bristol Myers Squibb? | www.fool.com | 2 | Neutral |
| Appeals Court Throws Out Alex Berenson's Case Against Pfizer Executives | www.theepochtimes.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone -99: 0 positive, 0 neutral and 1 negative. Showing all 1.
- abc11.com · 1 outletPfizer layoffs announced at Rocky Mount, Sanford facilities in NCNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Pfizer layoffs announced at Rocky Mount, Sanford facilities in NC | abc11.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Pfizer Inc., not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.